Incline Global Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-117,924
Closed -$32.1M 29
2015
Q3
$32.1M Buy
117,924
+35,520
+43% +$10.9M 7.07% 1
2015
Q2
$25M Buy
82,404
+9,469
+13% +$2.82M 5.55% 2
2015
Q1
$21.7M Buy
72,935
+19,675
+37% +$5.61M 5.4% 2
2014
Q4
$13.7M Buy
53,260
+2,170
+4% +$542K 4.05% 10
2014
Q3
$12.3M Buy
51,090
+230
+0.5% +$51.5K 3.69% 3
2014
Q2
$11.3M Buy
50,860
+10,230
+25% +$2.12M 4.25% 2
2014
Q1
$8.36M Hold
40,630
4.54% 4
2013
Q4
$6.83M Buy
+40,630
New +$6.35M 4.37% 9

Other funds holding AGN

Incline Global Management's AGN Position: Q4 2015 in Review

Incline Global Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 117,924 shares — an estimated $32.1M sold.

Incline Global Management first reported a position in AGN in Q4 2013 and held it in 8 quarters. The position peaked at $32.1M in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Incline Global Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Incline Global Management sold 117,924 Allergan plc shares in Q4 2015, an estimated $32.1M.
  • Incline Global Management first reported a position in Allergan plc in Q4 2013 and held it in 8 quarters.
  • Incline Global Management's Allergan plc position peaked at $32.1M in Q3 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Incline Global Management's 13F filing for Q4 2015, filed 16 Feb 2016.